Matrix metalloproteinases and oral cancer

Oral Oncology

Volumn 35, Issue 3, 1999, Pages 227-233

  Thomas, G T ^a   Lewis, M P ^a   Speight, P M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Matrix metalloproteinases; MMPs; Mouth; Oral cancer; Squamous cell carcinoma

Indexed keywords

GELATINASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

CELL MIGRATION; ENZYME ACTIVATION; ENZYME SPECIFICITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOUTH CANCER; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; REVIEW; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

EID: 0033018315     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00004-4     Document Type: Article

References (52)

1. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Current Opinions in Cell Biology. 7:1995;728-735.
2. Basbaum C.B., Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix at the cell surface. Current Opinions in Cell Biology. 8:1996;731-738.
3. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:1997;439-442.
4. Murphy, G., Reynolds, J.J. Extracellular matrix degradation. In: Connective Tissue and its Heritable Disorders. Royce PM, Steinman B, editors. New York: Wiley-Liss, 1993. p. 287-316.
5. Burton-Wurster N., Lust G., MacLeod J.N. Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. Matrix Biology. 15:1997;441-454.
6. dOrtho M.P., Will H., Atkinson S., et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. European Journal of Biochemistry. 250:1997;751-757.
7. Denhardt D.T., Feng B., Edwards D.R., Cocuzzi E.T., Malyankar U.M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmaceutical Therapeutics. 59:1993;329-341.
8. Apte S.S., Mattei M.G., Olsen B.R. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinase-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics. 19:1994;86-90.
9. Apte S.S., Hayashi K., Seldin M.F., Mattei M.G., Hayashi M., Olsen B.R. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10. Developmental Dynamics. 200:1994;177-197.
10. Leco K.J., Khokha R., Pavloff N., Hawkes S.P., Edwards D.R. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. Journal of Biological Chemistry. 269:1994;9532-9560.
11. Leco K.J., Apte S.S., Taniguchi G.T., et al. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Letters 1997; 401:213-217.
12. Stetler-Stevenson W.G., Liotta L.A., Kleiner D.E. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB Journal. 7:1993;1434-1441.
13. Bigg H.F., Shi Y.E., Liu Y., Steffensen B., Overall C.M. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A-TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. Journal of Biological Chemistry. 272:1997;15 496-15 500.
14. Ellis V. Cellular receptors for plasminogen activators. Trends in Cardiovascular Medicine. 7:1997;227-234.
15. Vassalli J-D, Pepper M.S. Membrane proteases in focus. Nature. 370:1994;14-15.
16. Jones J.L., Walker R.A. Control of matrix metalloproteinase activity in cancer. Journal of Pathology. 183:1997;377-379.
17. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., et al. Matrix metalloproteinases: a review. Critical Reviews in Oral Biology and Medicine. 4:1993;197-250.
18. MacDougall J.R., Matrisian L.M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer and Metastasis Reviews. 14:1995;351-362.
19. Stetler-Stevenson W.G., Hewitt R., Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Seminars in Cancer Biology. 7:1996;147-154.
20. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response. American Journal of Pathology. 149:1996;273-282.
21. Poulsom R., Pignatelli M., Stetler-Stevenson W.G., et al. Stromal expression of 72kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. American Journal of Pathology. 41:1992;389-396.
22. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. Journal of the National Cancer Institute. 86:1994;299-304.
23. Imren S., Kohn D.B., Shimada H., Blavier L., De Clerck Y.A. Overexpression of tissue inhibitor of metalloproteinase-2 by retroviral-mediated gene transfer in vivo, inhibits tumor growth and invasion. Cancer Research. 56:1996;2891-2895.
24. Polette M., Clavel C., Muller D., Abecassis J., Binninger I., Birembaut P. Detection of mRNAs encoding collagenase 1 and stromelysin 2 in carcinomas of the head and neck by in situ hybridisation. Invasion and Metastasis. 11:1991;76-83.
25. Polette M., Clavel C., Birembaut P., De Clerck Y.A. Localisation by in situ hybridisation of mRNAs encoding stromelysin 3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathology Research and Practice. 189:1993;1052-1057.
26. Gray S.T., Wilkins R.J., Yun K. Interstitial collagenase gene expression in oral squamous cell carcinoma. American Journal of Pathology. 141:1992;301-306.
27. Pyke C., Ralfkioer E., Huhtala P., Hurskainen T., Dano K., Tryggvason K. Localisation of mRNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridisation. Cancer Research. 52:1992;1336-1341.
28. Muller D., Wolf C., Abecassis J., et al. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Research. 53:1993;165-169.
29. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. American Journal of Clinical Pathology. 99:1993;18-23.
30. Kusukawa J., Sasaguri Y., Morimatsu M., Kameyama T. Expression of matrix metalloproteinase-3 in stage I and II squamous, cell carcinoma of the oral cavity. Journal of Oral and Maxillofacial Surgery. 3:1995;530-534.
31. Okada Y., Bellocq J-P., Rouyer N., et al. Membrane type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Proceedings of the National Academy of Science USA. 92:1995;2730-2734.
32. Yoshizaki Y., Sato H., Maruyama Y., et al. Increased expression of membrane type-1 matrix metalloproteinase in head and neck carcinoma. Cancer. 79:1997;139-144.
33. Charous S.J., Stricklin G.P., Nanney L.B., Netterville J.L., Burkey B.B. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Annals of Otology, Rhinology and Laryngology. 106:1997;271-278.
34. Airola K., Johansson N., Kariniemi A-L., Kahari V-M., Saarialho-Kere U. Human collagenase-3 is expressed in malignant epithelium of the skin. Journal of Investigative Dermatology. 109:1997;225-231.
35. Johansson N., Airola K., Grenman R., Kariniemi A-L., Saarialho-Kere U., Kahari V-M. Expression of collagenase-3 (matrix metalloproteinase 13) in squamous cell carcinoma of the head and neck. American Journal of Pathology. 151:1997;499-508.
36. Lyons J.G., Lin H.-Y., Salo T., et al. Expression of collagen-cleaving matrix metalloproteinases by keratinocytes. Effect of growth factors and cytokines and of microbial mediators. In: Hamada S., Holt S.C., McGhee J.R., editors. Periodontal Disease: Pathogens and Host Immune Responses. Tokyo: Quintessence Publishing 1991. p. 291-305.
37. Salo T., Lyons J.G., Raheratulle F., Birkedal-Hansen H., Larjava H. Transforming growth factor-b1 upregulates type IV collagenase expression in cultured human keratinocytes. Journal of Biological Chemistry. 266:1991;11436-11441.
38. Sutinen M., Kainulainen T., Hursaiken T., et al. Expression of matrix metalloproteinases (MMP-1 and -2 - and their inhibitors (TIMP-1, -2 and -3) in oral premalignant lesions, oral squamous cell carcinoma and lymph node metastasis. British Journal of Cancer. 77:1998;2239-2245.
39. Salo T., Makela Kylmanietni M., Autio-Harmainen H., Larjava H. Expression of Matrix Metalloproteinase-2 and -9 during early human wound healing. Laboratory Investigation. 70:1994;176-182.
40. Stahle-Backdahl Parks W.C. 92-kD gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. American Journal of Pathology. 142:1993;995-1000.
41. Juarez J., Clayman G., Nakajima M., et al. Role and regulation of expression of 92kDa typer- IV collagenase (MMP-9) in 2 invasive squamous cell carcinoma cell lines of the oral cavity. International Journal of Cancer. 55:1993;10-18.
42. Jones J., Watt F.M., Speight P.M. Changes in the expression of αv integrins in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 26:1997;63-68.
43. Thomas G.J., Lewis M.P., Speight P.M. Regulation of matrix metalloproteinase (MMP) production by αv integrins in oral carcinoma cell lines. Journal of Dental Research. 79:1998;641(A).
44. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., Morimatsu M. Production of matrix metalloproteinase 2 (gelatinase/type IV collagenase and 3 (stromelysin) by cultured oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 21:1992;221-224.
45. Masson R., Lefebre O., Noel A., et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. Journal of Cell Biology. 40:1998;1535-1541.
46. Dunsmore S.E., Rubin J.S., Kovacs S.O., Chedid M, Parks WC, Welgus H.G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. Journal of Biological Chemistry. 271:1996;24576-24582.
47. Putnins E.E., Firth J.D., Uitto V-J. Keratinocyte growth factor stimulation of gelatinase (matrix metalloproteinase-9) and plasminogen activator in histiotypic epithelial cell culture. Journal of Investigative Dermatology. 104:1995;989-994.
48. Damsky C.H., Werb Z. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Current Opinions in Cell Biology. 4:1992;772-781.
49. Larjava H., Lyons J.G., Salo T., et al. Anti-integrin antibodies induce type-IV collagenase expression in keratinocytes. Journal of Cellular Physiology. 157:1993;190-200.
50. Saarialho-Kere U.K., Kovacs S.O., Pentland A.P., Olerud J.E., Welou H.C.J.S., Parks W.C. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. Journal of Clinical Investigation. 92:1993;2858-2866.
51. 5 integrin receptor and induces de novo expression of the αvβ6 heterodimer in normal keratinocytes: implications for wound healing. Journal of Cell Biology. 129:1995;853-865.
52. Edwards D.R., Murphy G. Proteases-invasion and more. Nature. 394:1998;527-528.